SCHEMBL22949537

SCHEMBL22949537

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc5c(c4)S(c4ccc6ccccc6c4)(c4ccc6ccccc6c4)c4ccccc4-5)n3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
ALDH1A1 P00352 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
KDM4E B2RXH2 2/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MAPT P10636 3/20 0.35
HPGD P15428 2/20 0.35
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
LMNA P02545 2/20 0.33
APAF1 O14727 1/20 0.33
THRB P10828 1/20 0.33
XBP1 P17861 1/20 0.33
PTBP1 P26599 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22949027 0.99 MEN1 (0.41) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL22949326 0.97 MEN1 (0.40) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL22949681 0.97 MEN1 (0.40) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL22949665 0.94 MEN1 (0.38) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL22949612 0.92 MEN1 (0.39) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL22947522 0.88 MEN1 (0.39) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL22947556 0.86 MEN1 (0.40) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL22947646 0.85 MEN1 (0.40) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL22947695 0.85 MEN1 (0.40) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E
SCHEMBL22947682 0.84 NPC1 (0.41) MEN1KMT2AALDH1A1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 MEN1 2439/4885KMT2A 2115/4885ALDH1A1 752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.